Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 150-83-4
2. Sodium 3-hydroxybutanoate
3. Dl-3-hydroxybutyric Acid Sodium Salt
4. 306-31-0
5. Sodium;3-hydroxybutanoate
6. Sodium Beta-hydroxybutyrate
7. Dl-3-hydroxybutyric Acid, Sodium Salt
8. Butanoic Acid, 3-hydroxy-, Monosodium Salt
9. 3-hydroxybutyric Acid (sodium)
10. 19an4zh292
11. Dl-beta-hydroxybutyric Acid Sodium Salt
12. Butyric Acid, 3-hydroxy-, Monosodium Salt, (+/-)
13. 3-hydroxybutyric Acid Sodium Salt
14. Sodium 3-oxidanylbutanoate
15. (+/-)-sodium 3-hydroxybutyrate
16. Beta-hydroxybutyrate Sodium Salt
17. 1219804-68-8
18. Rac 3-hydroxybutyric Acid-d4 Sodium Salt
19. Sodium Dl-beta-hydroxybutyrate
20. Unii-19an4zh292
21. Mfcd00077788
22. Einecs 205-774-5
23. Dl-3-hydroxybutyricacidsodiumsalt
24. (+-)-3-hydroxybutanoic Acid Monosodium Salt
25. Butanoic Acid,3-hydroxy-, Sodium Salt (1:1)
26. Sodium Beta-hydroxybutanoate
27. 3-hydroxybutyric Acid Sodium
28. Sodium Dl-3-hydroxybutyrate
29. Schembl194589
30. Butanoic Acid, 3-hydroxy-, Monosodium Salt, (+-)-
31. Bet.-hydroxybutyrate Sodium Salt
32. Chembl3973787
33. Chebi:113373
34. Dtxsid201044130
35. Hms3369g04
36. Hms3373c05
37. 3-hydroxybutyric Acid, Sodium Salt
38. Amy10052
39. Mfcd00016716
40. Sodium .beta.-hydroxybutyrate
41. Akos015915737
42. Sodium 3-hydroxybutyrate, Dl-
43. Cs-w011168
44. Hy-w010452
45. Rac 3-hydroxybutyric Acid Sodium Salt
46. Sodium (+/-)-3-hydroxybutyrate
47. Sy107283
48. (+/-)-3-hydroxybutanoic Acid Sodium Salt
49. 3-hydroxybutanoic Acid Sodium Salt (1:1)
50. Ds-017796
51. Butanoic Acid,3-hydroxy-,sodium Salt(1:1)
52. Ft-0605057
53. Ft-0615838
54. Ft-0650657
55. Ft-0650956
56. Ft-0669446
57. Ft-0669447
58. H0231
59. Rac 3-hydroxybutyric Acid-[d4] Sodium Salt
60. .beta.-hydroxybutyric Acid Sodium Salt
61. H-4000
62. H-4001
63. H10236
64. (r)-(-)-3-hydroxybutyricacid,sodiumsalt
65. A805718
66. A807034
67. A809079
68. A908671
69. Q27193848
| Molecular Weight | 126.09 g/mol |
|---|---|
| Molecular Formula | C4H7NaO3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 126.02928836 g/mol |
| Monoisotopic Mass | 126.02928836 g/mol |
| Topological Polar Surface Area | 60.4 Ų |
| Heavy Atom Count | 8 |
| Formal Charge | 0 |
| Complexity | 73.7 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Sodium Dl-3-Hydroxybutyrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Dl-3-Hydroxybutyrate, including repackagers and relabelers. The FDA regulates Sodium Dl-3-Hydroxybutyrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Dl-3-Hydroxybutyrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sodium Dl-3-Hydroxybutyrate supplier is an individual or a company that provides Sodium Dl-3-Hydroxybutyrate active pharmaceutical ingredient (API) or Sodium Dl-3-Hydroxybutyrate finished formulations upon request. The Sodium Dl-3-Hydroxybutyrate suppliers may include Sodium Dl-3-Hydroxybutyrate API manufacturers, exporters, distributors and traders.
Sodium Dl-3-Hydroxybutyrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium Dl-3-Hydroxybutyrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium Dl-3-Hydroxybutyrate GMP manufacturer or Sodium Dl-3-Hydroxybutyrate GMP API supplier for your needs.
A Sodium Dl-3-Hydroxybutyrate CoA (Certificate of Analysis) is a formal document that attests to Sodium Dl-3-Hydroxybutyrate's compliance with Sodium Dl-3-Hydroxybutyrate specifications and serves as a tool for batch-level quality control.
Sodium Dl-3-Hydroxybutyrate CoA mostly includes findings from lab analyses of a specific batch. For each Sodium Dl-3-Hydroxybutyrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium Dl-3-Hydroxybutyrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium Dl-3-Hydroxybutyrate EP), Sodium Dl-3-Hydroxybutyrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium Dl-3-Hydroxybutyrate USP).
LOOKING FOR A SUPPLIER?
